ASSET MANAGERS TECH (AMT) is providing a new trade group resource for members of the asset management industry; namely, professional medical updates by Dr. Stanley Zaborowski concerning the status of proposed Coronavirus Vaccines and Herd Immunity. Many pharmaceutical companies committed to the production of vaccines relating to COVID - 19 are engaged in advanced testing stages at this time. How do these private sector initiatives dovetail with the approval processes of the relevant U.S. agencies and regulators? What are the practical considerations regarding the timeframe for distribution of the various coronavirus vaccines when they are deemed safe for use by those in need both domestically and on a global basis? And what will this anticipated momentum concerning such vaccines mean for the investment management industry.?
The main speaker at AMT's 9/24 Zoom Report is Dr. Stanley Zaborowski, who has extensive experience in the State of New Jersey on the front lines of treating patients in connection with infectious viruses. Dr. Zaborowski also serves as an adviser to local government officials in several suburban communities in NJ.
The scientific considerations concerning coronavirus vaccines are very important to professionals in the investment management industry. So as a trade group, we are pleased to be delivering detailed insights on this matter to you and other AMT constituents. Please spread the word at your firm and feel free to join our 9/24 Special Zoom Report with your colleagues - share this with others who are Working From Home!
Thank you for your consideration,